Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease

J Clin Immunol. 2012 Aug;32(4):736-45. doi: 10.1007/s10875-012-9652-9. Epub 2012 Mar 6.

Abstract

Our lab recently identified a cross-reactive antibody response between human T-lymphotropic virus type-1-p24-(gag) (HTLV-1-p24-(gag)) and peroxiredoxin-1 (PrX-1) as potentially contributing to the pathogenesis of HTLV-1 associated neurological disease via molecular mimicry. These targets proteins were glycosylated, yet the glycan side chains immunoreactive with the immunoglobulins were unknown. Using a combination of lectin isolation and serial enzymatic deglycosylation of glycoproteins, we determined that the immunoreactive epitopes contained branched oligomannose side chains. These data suggest that post-translational glycosylation specifically related to oligomannose immunoreactivity to both the infecting and host antigens may contribute to molecular mimicry and be important in the pathogenesis of HTLV-1 associated neurological disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Cell Line
  • Cross Reactions
  • Epitopes / immunology
  • Glycosylation
  • Human T-lymphotropic virus 1 / immunology*
  • Human T-lymphotropic virus 1 / pathogenicity
  • Humans
  • Molecular Mimicry
  • Nervous System Diseases / immunology*
  • Nervous System Diseases / virology
  • Oligosaccharides / immunology*
  • Paraparesis, Tropical Spastic / immunology*
  • Peroxiredoxins / immunology*
  • Protein Processing, Post-Translational
  • Retroviridae Proteins, Oncogenic / immunology*

Substances

  • Epitopes
  • Oligosaccharides
  • Retroviridae Proteins, Oncogenic
  • oligomannoside
  • p24 protein, Human T-lymphotropic virus 1
  • PRDX1 protein, human
  • Peroxiredoxins